Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Donald Catanzaro

Concepts (141)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Mycobacterium tuberculosis
28
2025
287
4.220
Why?
Tuberculosis, Multidrug-Resistant
14
2023
40
3.220
Why?
Antitubercular Agents
19
2023
106
2.550
Why?
Tuberculosis
11
2025
149
1.980
Why?
Drug Resistance, Multiple, Bacterial
13
2023
64
1.400
Why?
Microbial Sensitivity Tests
16
2023
271
1.280
Why?
Extensively Drug-Resistant Tuberculosis
8
2023
12
1.100
Why?
Latent Tuberculosis
4
2024
10
0.850
Why?
Molecular Diagnostic Techniques
7
2025
33
0.780
Why?
Tuberculosis, Pulmonary
6
2024
108
0.730
Why?
Mutation
10
2020
1292
0.620
Why?
Bacterial Proteins
9
2023
371
0.580
Why?
Population Dynamics
1
2016
17
0.550
Why?
Fluoroquinolones
5
2023
24
0.520
Why?
Drug Resistance, Bacterial
4
2017
72
0.510
Why?
Sequence Analysis, DNA
8
2019
237
0.450
Why?
Isoniazid
6
2023
36
0.400
Why?
DNA, Bacterial
6
2019
186
0.370
Why?
Humans
36
2025
50389
0.310
Why?
Air Pollution
2
2019
45
0.300
Why?
Air Pollutants
2
2019
65
0.300
Why?
India
6
2018
52
0.290
Why?
Adult
15
2025
13568
0.280
Why?
Middle Aged
13
2025
12460
0.260
Why?
Young Adult
10
2025
4064
0.250
Why?
Sputum
5
2016
65
0.250
Why?
Moldova
7
2024
11
0.250
Why?
California
3
2019
87
0.240
Why?
Sensitivity and Specificity
7
2025
875
0.230
Why?
Prospective Studies
8
2025
2414
0.220
Why?
Mycobacterium Infections, Nontuberculous
1
2022
20
0.200
Why?
High-Throughput Nucleotide Sequencing
3
2019
168
0.200
Why?
Tuberculosis, Lymph Node
1
2022
2
0.200
Why?
Lung Diseases
1
2023
98
0.200
Why?
Directly Observed Therapy
2
2020
7
0.200
Why?
Male
14
2025
25718
0.200
Why?
Disease Progression
1
2024
823
0.190
Why?
South Africa
6
2018
22
0.190
Why?
Aged
9
2025
9590
0.190
Why?
Pneumonia
1
2022
118
0.190
Why?
Female
14
2025
26981
0.190
Why?
Laboratories
1
2020
20
0.180
Why?
Residence Characteristics
2
2019
153
0.180
Why?
Trees
1
2019
18
0.170
Why?
Urban Health Services
1
2019
21
0.170
Why?
Bacteriological Techniques
2
2017
42
0.170
Why?
Health Care Costs
2
2018
168
0.170
Why?
Transcriptome
1
2021
316
0.160
Why?
DNA Gyrase
2
2015
3
0.150
Why?
Catalase
2
2015
68
0.150
Why?
HIV Infections
1
2022
355
0.150
Why?
Adolescent
8
2025
6475
0.150
Why?
Kanamycin
4
2023
6
0.150
Why?
Vehicle Emissions
1
2017
10
0.150
Why?
ROC Curve
1
2017
239
0.130
Why?
Genotyping Techniques
1
2016
20
0.130
Why?
Specimen Handling
1
2016
54
0.130
Why?
Cohort Studies
2
2017
1426
0.130
Why?
Risk Factors
3
2024
3692
0.130
Why?
Child
7
2025
6877
0.130
Why?
Rifampin
3
2023
62
0.120
Why?
Socioeconomic Factors
1
2016
590
0.120
Why?
Capreomycin
3
2023
4
0.110
Why?
Logistic Models
1
2016
900
0.110
Why?
Genotype
4
2017
539
0.110
Why?
Point Mutation
1
2013
65
0.110
Why?
Dose-Response Relationship, Drug
1
2017
1356
0.110
Why?
Prevalence
1
2016
970
0.110
Why?
Aged, 80 and over
5
2020
3180
0.110
Why?
Interferon-gamma
2
2024
176
0.100
Why?
Research Design
1
2014
344
0.100
Why?
Promoter Regions, Genetic
4
2016
467
0.100
Why?
Lung
1
2016
512
0.100
Why?
Cross-Sectional Studies
1
2016
1590
0.090
Why?
Risk Assessment
2
2017
1258
0.090
Why?
Lyme Disease
1
2011
32
0.090
Why?
Predictive Value of Tests
3
2022
934
0.090
Why?
Oxidoreductases
3
2015
59
0.090
Why?
Environment
1
2011
83
0.090
Why?
Anti-Bacterial Agents
2
2015
745
0.090
Why?
Polymorphism, Single Nucleotide
3
2019
482
0.080
Why?
Antigens, Bacterial
2
2024
54
0.080
Why?
Reproducibility of Results
3
2019
1201
0.080
Why?
Amikacin
2
2023
19
0.080
Why?
Phenotype
3
2015
736
0.070
Why?
Incidence
2
2024
1017
0.070
Why?
Time Factors
3
2019
2934
0.070
Why?
Cost-Benefit Analysis
2
2019
270
0.060
Why?
Pakistan
1
2025
19
0.060
Why?
Contact Tracing
1
2024
9
0.060
Why?
Philippines
2
2015
9
0.060
Why?
Epitopes, T-Lymphocyte
1
2024
25
0.060
Why?
Tuberculin Test
1
2023
9
0.060
Why?
Interferon-gamma Release Tests
1
2023
8
0.050
Why?
Peptides
1
2024
221
0.050
Why?
Mitochondrial Dynamics
1
2022
21
0.050
Why?
Kenya
1
2022
10
0.050
Why?
Pathology, Molecular
1
2022
22
0.050
Why?
Proteome
1
2024
159
0.050
Why?
England
1
2021
45
0.050
Why?
Tissue Array Analysis
1
2021
45
0.050
Why?
State Medicine
1
2021
14
0.050
Why?
San Francisco
1
2020
12
0.040
Why?
United States
2
2022
4913
0.040
Why?
New York City
1
2020
26
0.040
Why?
Ofloxacin
1
2019
7
0.040
Why?
Longitudinal Studies
1
2021
709
0.040
Why?
Algorithms
1
2022
618
0.040
Why?
Costs and Cost Analysis
1
2018
92
0.040
Why?
Video Recording
1
2018
79
0.040
Why?
Case-Control Studies
1
2021
1148
0.040
Why?
Pyrazinamide
1
2017
7
0.040
Why?
Medication Adherence
1
2018
129
0.040
Why?
Child, Preschool
2
2016
3908
0.030
Why?
DNA Mutational Analysis
1
2017
176
0.030
Why?
Kanamycin Resistance
1
2016
1
0.030
Why?
Molecular Typing
1
2016
10
0.030
Why?
Risk
1
2017
316
0.030
Why?
Gene Expression Profiling
1
2021
1029
0.030
Why?
Genes, Bacterial
1
2016
64
0.030
Why?
Bacterial Load
1
2016
12
0.030
Why?
Proportional Hazards Models
1
2017
418
0.030
Why?
Reference Standards
1
2016
52
0.030
Why?
Calibration
1
2016
58
0.030
Why?
Nucleic Acid Hybridization
1
2016
55
0.030
Why?
Environmental Exposure
1
2017
199
0.030
Why?
Pharmaceutical Preparations
1
2016
76
0.030
Why?
Survival Analysis
1
2017
671
0.030
Why?
Genetic Loci
1
2015
44
0.030
Why?
Gene Frequency
1
2015
95
0.030
Why?
Meta-Analysis as Topic
1
2015
38
0.030
Why?
DNA-Directed RNA Polymerases
1
2014
14
0.030
Why?
Clinical Protocols
1
2014
109
0.030
Why?
Time-to-Treatment
1
2014
70
0.030
Why?
Pilot Projects
1
2016
704
0.030
Why?
Base Sequence
1
2014
657
0.030
Why?
Acetyltransferases
1
2012
19
0.030
Why?
Methyltransferases
1
2012
29
0.020
Why?
Treatment Outcome
1
2022
5230
0.020
Why?
Maryland
1
2011
32
0.020
Why?
Models, Biological
1
2011
723
0.020
Why?
Catanzaro's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Similar People Expand Description
_